A

Anexigen

10 employees

Anexigen is a developer of novel methods and compositions designed to combat existing and burgeoning antimicrobial threats.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Antibiotic Development
Antimicrobial Resistance
Therapeutics
Infectious Diseases
Pharmaceutical
Drug Development
Targeted Therapies

Date founded

2018

Funding rounds raised

A

Anexigen raised undisclosed on January 1, 2020

Investors: Correlation Ventures

FAQ